Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma
EV-302 的探索性亚组分析:一项评估恩福妥单抗联合帕博利珠单抗与化疗治疗既往未接受治疗的局部晚期或转移性尿路上皮癌的 III 期全球研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105544
van der Heijden, M S; Powles, T; Gupta, S; Loriot, Y; Galsky, M D; Valderrama, B P; Sridhar, S S; Yu, E Y; Iyer, G; Kikuchi, E; Castellano, D; Hoffman-Censits, J; Drakaki, A; Mar, N; Maroto Rey, J P; Vulsteke, C; Arafat, W; Duran, I; Dawson, N A; Swami, U; Gorla, S; Moreno, B H; Yu, X; Lu, Y-T; Bedke, J